NGeneBio Co., Ltd of Seoul at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine
Manufacturers

NGeneBio Co., Ltd

1104, Hanhwa Bizmetro, 242, Digital-ro, Guro-gu, 08394 Seoul
Korea, Republic
Telephone +82 2 8679798
Fax +82 2 8669784
mihyeon.j@ngenebio.com

This company is co-exhibitor of
Korea Medical Devices Industrial Coop. Association (KMDICA)

Hall map

MEDICA 2018 hall map (Hall 7a): stand C09

Fairground map

MEDICA 2018 fairground map: Hall 7a

Contact

YoungJoon Moon

Director
Global Business Div.

1010, Hanhwa Bizmetro, 242, Digital-ro, Guro-gu
08394 Seoul, Korea, Republic

Phone
82-2-867-9798

Fax
82-2-866-9784

Email
yj.moon@ngenebio.com

MiHyeon Jang

Deputy General Manager
Global Business Div. Global Sales&MKT Team

1010, Hanhwa Bizmetro, 242, Digital-ro, Guro-gu
08394 Seoul, Korea, Republic

Phone
82-2-867-9798

Fax
82-2-866-9784

Email
mihyeon.j@ngenebio.com

Kathy KeunSook Lee

Deputy General Manager
Global Business Div. Global Sales&MKT Team

1010, Hanhwa Bizmetro, 242, Digital-ro, Guro-gu
08394 Seoul, Korea, Republic

Phone
82-2-867-9798

Fax
82-2-866-9784

Email
ks.kathy.lee@ngenebio.com

Our range of products

Product categories

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

Our products

Product category: DNA testing

BRCAaccuTest

- NGS IVD kit to detect BRCA1/2 mutations for breast/ovarian cancer predisposition.
- CE-IVD marked and Korean Ministry of Food and Drug Safety (MFDS)-IVD approval with clinical trial data in 2017.
- BRCAaccuTest PLUS launched for both of somatic & germline BRCA1/2 testing (CE-IVD)

More Less

Product category: DNA testing

NGeneAnalySys

- Clinical NGS data analysis SW for variant calling, annotation, QC and clinical report generation.
- CE-IVD marked and Korean MFDS-IVD approval in 2017, combined with BRCAaccuTest.
- Also compatible with SOLIDaccuTest & HEMEaccuTest (CE-IVD) providing relevant therapy information in clinical report.

More Less

Product category: DNA testing

HEMEaccuTest

- Hematologic malignancy NGS kit and clinical analysis SW to cover 108 genes related to AML, ALL, lymphoma and multiple myeloma etc.
- Tested with clinical samples
- CE-IVD marked in Oct/2018

More Less

Product category: DNA testing

SOLIDaccuTest

- Solid tumor NGS panel and clinical analysis SW to cover 84 genes related to lung, colon, breast/ovarian and gastric cancer etc.
- DNA (84 genes) / RNA (28 fusion genes) can be tested
- Tested with clinical samples

More Less

Product category: DNA testing

IDaccuTest

- Autosomal STR (A-STR 16 & 9plex) and Y-chromosome STR (Y-STR) kits for forensic/paternity DNA test.
- Reference guidelines: CODIS & SWAGDAM
- Over 1,000 samples tested / ILAC certified lab tested

More Less

About us

Company details

NGeneBio was founded in 2015 as a spin-off venture from Korea Telecom, develops in vitro diagnostics (IVD)/companion diagnostics (CDx) products and bioinformatics SW with cutting-of-edge technologies including next generation sequencing (NGS). The company launched NGS-based breast/ovarian cancer panel (BRCAaccuTest) with clinical analysis SW (NGeneAnalySys) and received CE-IVD and KFDA approval in 2017. Currently launched NGS panels and SW for solid tumor and hematological malignancies. Short Tandem Repeat (STR) kits, IDaccuTest, compatible with Sanger sequencer for forensic/parental genetic testing were also launched.

More Less

Company information as a PDF file